Annual EBIT
-$231.82 M
-$52.03 M-28.94%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual earnings before interest & taxes is -$231.82 million, with the most recent change of -$52.03 million (-28.94%) on December 31, 2023.
- During the last 3 years, AXSM annual EBIT has fallen by -$131.49 million (-131.05%).
- AXSM annual EBIT is now -12503.29% below its all-time high of -$1.84 million, reached on December 31, 2013.
Performance
AXSM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$62.62 M
+$15.42 M+19.76%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly earnings before interest & taxes is -$62.62 million, with the most recent change of +$15.42 million (+19.76%) on September 30, 2024.
- Over the past year, AXSM quarterly EBIT has increased by +$35.65 million (+36.28%).
- AXSM quarterly EBIT is now -3590.93% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$306.22 M
-$504.00 K-0.16%
September 30, 2024
Summary
- As of February 7, 2025, AXSM TTM earnings before interest & taxes is -$306.22 million, with the most recent change of -$504.00 thousand (-0.16%) on September 30, 2024.
- Over the past year, AXSM TTM EBIT has dropped by -$74.39 million (-32.09%).
- AXSM TTM EBIT is now -17947.92% below its all-time high of -$1.70 million, reached on September 30, 2014.
Performance
AXSM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AXSM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.9% | +36.3% | -32.1% |
| 3 y3 years | -131.1% | -87.5% | -155.6% |
| 5 y5 years | -676.9% | -233.0% | -356.3% |
AXSM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.9% | at low | -882.5% | +36.3% | -145.6% | at low |
| 5 y | 5-year | -245.5% | at low | -882.5% | +36.3% | -356.3% | at low |
| alltime | all time | <-9999.0% | at low | -3590.9% | +36.3% | <-9999.0% | at low |
Axsome Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$62.62 M(-19.8%) | -$306.22 M(+0.2%) |
| Jun 2024 | - | -$78.05 M(+16.0%) | -$305.71 M(+4.4%) |
| Mar 2024 | - | -$67.28 M(-31.5%) | -$292.73 M(+26.3%) |
| Dec 2023 | -$231.82 M(+28.9%) | -$98.27 M(+58.2%) | -$231.82 M(+19.8%) |
| Sep 2023 | - | -$62.12 M(-4.5%) | -$193.47 M(+11.3%) |
| Jun 2023 | - | -$65.06 M(+920.7%) | -$173.76 M(+17.5%) |
| Mar 2023 | - | -$6.37 M(-89.4%) | -$147.88 M(-17.8%) |
| Dec 2022 | -$179.80 M(+44.2%) | -$59.92 M(+41.3%) | -$179.80 M(+17.9%) |
| Sep 2022 | - | -$42.41 M(+8.2%) | -$152.49 M(+6.3%) |
| Jun 2022 | - | -$39.18 M(+2.3%) | -$143.49 M(+6.2%) |
| Mar 2022 | - | -$38.29 M(+17.4%) | -$135.15 M(+8.4%) |
| Dec 2021 | -$124.71 M(+24.3%) | -$32.61 M(-2.4%) | -$124.71 M(+4.1%) |
| Sep 2021 | - | -$33.41 M(+8.3%) | -$119.79 M(+10.1%) |
| Jun 2021 | - | -$30.85 M(+10.8%) | -$108.76 M(+13.7%) |
| Mar 2021 | - | -$27.84 M(+0.6%) | -$95.69 M(-4.6%) |
| Dec 2020 | -$100.33 M(+49.5%) | -$27.69 M(+23.8%) | -$100.33 M(+3.4%) |
| Sep 2020 | - | -$22.37 M(+25.8%) | -$97.07 M(+3.8%) |
| Jun 2020 | - | -$17.78 M(-45.3%) | -$93.51 M(+4.9%) |
| Mar 2020 | - | -$32.49 M(+33.0%) | -$89.18 M(+32.9%) |
| Dec 2019 | -$67.11 M | -$24.43 M(+29.9%) | -$67.11 M(+29.0%) |
| Sep 2019 | - | -$18.81 M(+39.9%) | -$52.03 M(+26.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$13.45 M(+29.0%) | -$41.23 M(+15.3%) |
| Mar 2019 | - | -$10.42 M(+11.5%) | -$35.77 M(+19.9%) |
| Dec 2018 | -$29.84 M(+8.1%) | -$9.35 M(+16.7%) | -$29.84 M(+8.2%) |
| Sep 2018 | - | -$8.01 M(+0.3%) | -$27.58 M(+7.5%) |
| Jun 2018 | - | -$7.99 M(+77.9%) | -$25.66 M(+5.1%) |
| Mar 2018 | - | -$4.49 M(-36.7%) | -$24.42 M(-11.5%) |
| Dec 2017 | -$27.60 M(+2.0%) | -$7.09 M(+16.4%) | -$27.60 M(-0.2%) |
| Sep 2017 | - | -$6.09 M(-9.8%) | -$27.66 M(-3.9%) |
| Jun 2017 | - | -$6.75 M(-12.0%) | -$28.78 M(-0.3%) |
| Mar 2017 | - | -$7.67 M(+7.3%) | -$28.86 M(+6.6%) |
| Dec 2016 | -$27.07 M(+135.9%) | -$7.15 M(-0.8%) | -$27.07 M(+6.8%) |
| Sep 2016 | - | -$7.21 M(+5.6%) | -$25.35 M(+25.7%) |
| Jun 2016 | - | -$6.83 M(+16.1%) | -$20.17 M(+30.7%) |
| Mar 2016 | - | -$5.88 M(+8.3%) | -$15.42 M(+33.5%) |
| Dec 2015 | -$11.47 M(+109.1%) | -$5.43 M(+168.4%) | -$11.55 M(+43.2%) |
| Sep 2015 | - | -$2.02 M(-2.9%) | -$8.07 M(+4.2%) |
| Jun 2015 | - | -$2.08 M(+3.6%) | -$7.74 M(+36.9%) |
| Mar 2015 | - | -$2.01 M(+3.2%) | -$5.66 M(+55.2%) |
| Dec 2014 | -$5.49 M(+198.4%) | -$1.95 M(+14.8%) | -$3.65 M(+114.8%) |
| Sep 2014 | - | -$1.70 M | -$1.70 M |
| Dec 2013 | -$1.84 M | - | - |
FAQ
- What is Axsome Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Axsome Therapeutics?
- What is Axsome Therapeutics annual EBIT year-on-year change?
- What is Axsome Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly EBIT year-on-year change?
- What is Axsome Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Axsome Therapeutics?
- What is Axsome Therapeutics TTM EBIT year-on-year change?
What is Axsome Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AXSM is -$231.82 M
What is the all time high annual EBIT for Axsome Therapeutics?
Axsome Therapeutics all-time high annual earnings before interest & taxes is -$1.84 M
What is Axsome Therapeutics annual EBIT year-on-year change?
Over the past year, AXSM annual earnings before interest & taxes has changed by -$52.03 M (-28.94%)
What is Axsome Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AXSM is -$62.62 M
What is the all time high quarterly EBIT for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly earnings before interest & taxes is -$1.70 M
What is Axsome Therapeutics quarterly EBIT year-on-year change?
Over the past year, AXSM quarterly earnings before interest & taxes has changed by +$35.65 M (+36.28%)
What is Axsome Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AXSM is -$306.22 M
What is the all time high TTM EBIT for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM earnings before interest & taxes is -$1.70 M
What is Axsome Therapeutics TTM EBIT year-on-year change?
Over the past year, AXSM TTM earnings before interest & taxes has changed by -$74.39 M (-32.09%)